Help Lines 954-785-1121
 


You are not logged in. Upgrade Here
 <<<Previous Mid Day Report     Next Mid Day Report >>> 
 <<<Previous After Market Report Next After Market Report >>> 
You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

 MIDDAY BREAKOUTS REPORT - TUESDAY, JULY 2ND, 2024
Previous Mid Day Report Next Mid Day Report >>>

DOW 39111.86 -57.66 (-0.15%) | NASDAQ 17900.75 21.45 (0.12%) | S&P 500 5475.73 0.64 (0.01%)
Time of Screening : 7/2/2024 12:42:33 PM         Report Released : 7/2/2024 1:02:11 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 65% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page
Symbol/Exchange
Company Name
Industry Group
PRICE CHANGE
(%Change)
Day High Volume
(% DAV)
(50 DAV)
52 Wk Hi
% From Hi
Date
Featured
Price
Featured
Pivot Point
Max Buy
NVO - NYSE
Novo Nordisk A/S Adr
$142.57 -2.85
-1.96%
$143.37 4,164,149
110.22% of 50 DAV
50 DAV is 3,778,000
$148.15
-3.77%
6/7/2024 $143.06 PP = $138.38
MB = $145.30
Most Recent Note - 7/2/2024 12:56:58 PM
Y - Color code is changed to yellow while consolidating back below its "max buy" level. Fundamentals remain strong. Prior highs in the $138 area define initial support to watch above its 50 DMA line ($135.22). See the latest FSU analysis for more details and an annotated graph.
>>> The latest Featured Stock Update with an annotated graph appeared on 7/1/2024. Click here.
View all notes | Alert me of new notes | Company Profile | SEC | News | ChartC A N S L I M

Symbol - Exchange - Industry Group
Company Name
Last Chg Day
High
52 WK Hi % From Hi Volume
% DAV
DAV
BLX - NYSE - BANKING - Foreign Regional Banks
Banco Latinoamericano C
$30.33 +0.35
1.17%
$30.41 $31.62 -4.08% 91,775
75.23%
122,000
Most Recent Note for BLX - 7/2/2024 12:44:11 PM
Rebounding above its 50 DMA line toward its 52-week high with today's 3rd consecutive volume-driven gain. Reported Mar '24 quarterly earnings +37% on +23% sales revenues versus the year ago period. Comparisons in prior quarters also showed very strong sales revenues and earnings increases. Up and down annual earnings (A criteria) history is a concern.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ENSG - NASDAQ - HEALTH SERVICES - Long-Term Care Facilities
Ensign Group Inc
$125.70 +1.56
1.26%
$126.08 $127.58 -1.47% 203,846
71.52%
285,000
Most Recent Note for ENSG - 7/2/2024 12:46:00 PM
Today's 4th consecutive volume-driven gain has it perched within close striking distance of its all-time high after consolidating above its 50 DMA line. Reported earnings +15% on +14% sales revenues for the Mar '24 quarter versus the year-ago period, and prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria). Annual earnings history has been strong.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
ESEA - NASDAQ - TRANSPORTATION - Shipping
Euroseas Ltd
$40.70 +2.45
6.41%
$41.60 $42.29 -3.76% 110,972
396.33%
28,000
Most Recent Note for ESEA - 7/2/2024 12:47:19 PM
Rebounded above its 50 DMA line ($36.69) on the prior session and challenging its 52-week high with today's gap up and 2nd consecutive big volume-driven gain. Prior mid-day reports cautioned members - "Reported Mar '24 quarterly earnings -14% on +11% sales revenues versus the year-ago period. Prior earnings and sales revenues growth history has been below the fundamental guidelines of the fact-based investment system.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
KEQU - NASDAQ - ELECTRONICS - Scientific & Technical Instrum
Kewaunee Scientific Corp
$45.91 +1.91
4.34%
$47.00 $47.36 -3.06% 12,846
80.29%
16,000
Most Recent Note for KEQU - 7/2/2024 12:50:16 PM
Perched at its all-time high with today's gain adding to a spurt of volume-driven gains. Reported strong earnings increases in recent quarters through Apr '24. Subpar sales revenues growth and annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
KGC - NYSE - METALS & MINING - Gold
Kinross Gold Corp
$7.93 -0.31
-3.76%
$8.39 $8.42 -5.82% 10,972,853
67.07%
16,360,000
Most Recent Note for KGC - 7/2/2024 12:52:14 PM
Retreating from a new 52-week high following volume-driven gains last week. Reported Mar '24 quarterly earnings +43% on +16% sales revenues versus the year ago period. Six of the 7 latest quarterly earnings increases were well above the +25% minimum guideline (C criteria). Its up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LINC - NASDAQ - DIVERSIFIED SERVICES - Education &; Training Services
Lincoln Educational Svcs
$11.91 +0.17
1.45%
$11.98 $13.05 -8.74% 105,061
77.25%
136,000
Most Recent Note for LINC - 7/2/2024 12:53:56 PM
Rebounded above its 50 DMA line ($11.23) with recent gains backed by above-average volume. Slumped from its 52-week high since noted with caution in the 5/17/24 mid-day report - "Reported Mar '24 quarterly earnings +100% on +18% sales revenues versus the year-ago period. Prior quarterly earnings comparisons have not been strong and steady above the +25% minimum guideline (C criteria) and its annual earnings (A criteria) history is also below guidelines."
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  
LLY - NYSE - Medical-Diversified
Lilly Eli & Co
$897.57 -16.80
-1.84%
$903.71 $916.83 -2.10% 2,376,873
86.97%
2,733,000
Most Recent Note for LLY - 7/2/2024 12:55:30 PM
Retreating today after hitting new all-time highs, wedging higher with recent gains lacking great volume conviction. Reported Mar '24 quarterly earnings +59% on +26% sales revenues versus the year-ago period. Fundamental concerns remain as the 2 prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria) of the fact-based investment system. It has made impressive price progress since dropped from the Featured Stocks list on 8/11/22.
View all notes | Alert me of new notes | Company Profile | SEC  | News | ChartC A N S L I M  

THESE ARE NOT BUY RECOMMENDATIONS!  Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time.  Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

 We appreciate any feedback members may wish to send via the inquiry form here.

Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us